Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.36 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.36 |
| ▸ | DPP4 | P27487 | 3/20 | 0.36 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.36 |
| ▸ | FAP | Q12884 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14486146 | 0.95 | BLM (0.48) | GSRALOX15BLMPMP22KMT2A | |
| SCHEMBL344574 | 0.89 | GSR (0.61) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL20240364 | 0.89 | GSR (0.61) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL1404247 | 0.89 | GSR (0.61) | GSRGNAI3GNAO1GNAI1DPP7 | |
| Hydrochloric Acid SCHEMBL3825519 | 0.87 | GSR (0.59) | GSRBLMGNAI3GNAO1GNAI1 | |
| Hydrochloric Acid SCHEMBL2099474 | 0.87 | GSR (0.59) | GSRBLMGNAI3GNAO1GNAI1 | |
| SCHEMBL680614 | 0.87 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL28313344 | 0.87 | ALOX15 (0.60) | GSRALOX15BLMPMP22KMT2A | |
| SCHEMBL711607 | 0.87 | ALOX15 (0.60) | GSRALOX15BLMPMP22KMT2A | |
| SCHEMBL890611 | 0.86 | GSR (0.55) | GSRALOX15BLMKMT2AGNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119816287-A | Encapsulation composition and cosmetic or pharmaceutical composition comprising liquid crystal particles and method for producing the same | ELC管理有限责任公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118382424-A | Personal care compositions | 高露洁-棕榄公司 | 2024-07-23 | — | — | CN | claimed |
| CN-118236281-A | Composition for stabilizing poorly soluble component and cosmetic composition containing same | 株式会社LG生活健康 | 2024-06-25 | — | — | CN | claimed |
| CN-116669686-A | Composition for lightening and/or whitening keratin materials | 莱雅公司 | 2023-08-29 | — | — | CN | claimed |
| CN-114159367-A | Long-acting hair blackening liquid and preparation method thereof | 广州莎莎化妆品制造有限公司 | 2022-03-11 | — | — | CN | claimed |
| US-11180770-B2 | HPPD variants and methods of use | BASF Agricultural Solutions Seed US LLC (US) | 2021-11-23 | — | — | US | claimed |
| US-8188012-B2 | Process of using hard brine at high alkalinity for enhanced oil recovery (EOR) applications | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-05-29 | — | — | US | claimed |
| EP-1292615-B1 | MODIFIED MORBILLIVIRUS V PROTEINS | WYETH CORP (US) | 2006-10-25 | — | — | EP | claimed |
| US-6664066-B2 | Mutant measles virus V protein; gene expression and engineering | WYETH HOLDINGS CORPORATION | 2003-12-16 | — | — | US | claimed |
| US-20030206925-A1 | MODIFIED MORBILLIVIRUS V PROTEINS | WYETH HOLDINGS CORPORATION | 2003-11-06 | — | — | US | claimed |
| EP-0832115-A1 | PROMOTION OF HOMOLOGOUS DNA PAIRING BY RecA-DERIVED PEPTIDES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-04-01 | — | — | EP | claimed |
| WO-1996040765-A1 | PROMOTION OF HOMOLOGOUS DNA PAIRING BY RecA-DERIVED PEPTIDES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996016982-A2 | ULTRASELECTIVE OPIOIDMIMETIC PEPTIDES AND PHARMACOLOGICAL AND THERAPEUTIC USES THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-06-06 | — | — | WO | claimed |
| EP-0149581-B1 | COMPOSITIONS CONTAINING OLIGO-MURAMYLPEPTIDES AND THEIR APPLICATION, IN PARTICULAR FOR THE ACTIVATION OF MACROPHAGES | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1987-07-22 | — | — | EP | claimed |
| CN-119816287-A | Encapsulation composition and cosmetic or pharmaceutical composition comprising liquid crystal particles and method for producing the same | ELC管理有限责任公司 | 2025-04-11 | — | — | CN | disclosed |
| US-12076388-B2 | Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins | ARAMIS BIOTECHNOLOGIES INC. (CA) | 2024-09-03 | — | — | US | disclosed |
| CN-118382424-A | Personal care compositions | 高露洁-棕榄公司 | 2024-07-23 | — | — | CN | disclosed |
| WO-1992009296-A1 | A PEPTIDE WHICH REGULATES WEIGHT GAIN IN MAMMALS | GEORGETOWN UNIVERSITY (US) | 1992-06-11 | — | — | WO | disclosed |
| EP-0465122-A1 | Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as paf antagonists | MERCK & CO. INC. (US) | 1992-01-08 | — | — | EP | disclosed |
| EP-0395181-A1 | Stabilization of carboxyl esterase | GIST-BROCADES N.V. (NL) | 1990-10-31 | — | — | EP | disclosed |